Previous 10 | Next 10 |
Erin Darakjian to Retain Chief Accounting Officer Role P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced Atul Kavthekar will be joining the Company as...
P3 Health Partners Inc. (PIII) Q3 2022 Results Conference Call November 14, 2022 04:30 PM ET Company Participants Karen Blomquist - Vice President of Investor Relations Sherif Abdou - Chief Executive Officer Erin Darakjian - Interim Chief Financial Officer Am...
P3 Health Partners press release ( NASDAQ: PIII ): Q3 GAAP EPS of -$0.27. Revenue of $248.3M (+59.0% Y/Y) beats by $20.8M . Full-Year 2022 Outlook- The Company still expects full-year 2022 revenue between $1.025 billion and $1.075 billion, representing a 61%...
Strong Third-Quarter YTD 2022 revenue growth of 59% compared to the Third-Quarter YTD 2021 At-risk Medicare Advantage members exceeded 101,000 at the end of the Third Quarter of 2022 Third-Quarter YTD 2022 Net loss PMPM increased to $1,132 from $159 for Third-quarter...
Management to Host Conference Call and Webcast Monday November 14, 2022 at 4:30pm Eastern Time P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today ann...
P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, is scheduled to participate in a “fireside chat” at the Credit Suisse 31 st Annual Healthcare Conferen...
Health management company P3 Health Partners ( NASDAQ: PIII ) said it has received a letter from Nasdaq on the cure of a filing delinquency. The stock exchange wrote that the company is now in compliance with all applicable listing standards. PIII's securities will con...
P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, announces receipt of an October 24, 2022 letter (the “Compliance Letter”) from the Nasdaq Hearing Panel (t...
P3 Health Partners Inc. (PIII) Q2 2022 Earnings Conference Call October 20, 2022 04:30 PM ET Company Participants Karen Blomquist - Vice President, Investor Relations Sherif Abdou - Chief Executive Officer Eric Atkins - Chief Financial Officer Amir Bacchus - ...
P3 Health Partners press release ( NASDAQ: PIII ): Q2 GAAP EPS of -$3.73. Revenue of $269.45M (+86.4% Y/Y). At-risk Medicare Advantage members at June 30, 2022 grew to approximately 102,000, a 52% increase compared to 67,000 at the end of 2021. Adjusted EBITDA loss...
News, Short Squeeze, Breakout and More Instantly...
P3 Health Partners Inc. Company Name:
PIII Stock Symbol:
NASDAQ Market:
P3 Health Partners Inc. Website:
P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for second quarter 2024 and file its Quarterly Report on Form 10-Q on Wednesday, August 7...
P3 Health Partners will utilize Innovaccer’s Healthcare AI Platform for personalized interventions, improved outcomes, and cost-effective healthcare delivery for their patients. Innovaccer Inc. , a leading healthcare AI company, announced a new strategic partnership with P3...